Indication
Pituitary Disorders
2 clinical trials
3 products
Product
TransCon hGHClinical trial
enliGHten: A Multicenter, Phase 3, Long-Term, Open-Label Trial Investigating Safety and Efficacy of TransCon hGH Administered Once-Weekly in Children With Growth Hormone Deficiency (GHD) Who Have Completed a Prior TransCon hGH Clinical TrialStatus: Completed, Estimated PCD: 2023-02-21
Clinical trial
Identification and Clinical Relevance of an Oxytocin Deficient State: a Randomized, Crossover, Placebo-controlled, Proof-of-concept, Physiopathological Study (GLP1 Study)Status: Recruiting, Estimated PCD: 2024-04-30
Product
GLP1-RAProduct
Control